Targeting Multiple Arms of the Apoptotic Regulatory Machinery | Cancer Research
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT- 737 in acute myeloid leukemia - ScienceDirect
Proposed model for the synergistic mechanism of ABT-737 and MG-132... | Download Scientific Diagram
Cancers | Free Full-Text | The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death | HTML
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT- 737 in acute myeloid leukemia - ScienceDirect
B Cell Lymphoma 2 and Cancer Therapy | Encyclopedia MDPI
ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells | Leukemia
Frontiers | BH3 Mimetics for the Treatment of Prostate Cancer | Pharmacology
Mechanisms of potentiation of ABT-737 lethality by strategies targeting... | Download Scientific Diagram
Phosphorylation switches Bax from promoting to inhibiting apoptosis thereby increasing drug resistance | EMBO reports
Chemical structure and mode of action of the BH3 mimetic ABT-737 in... | Download Scientific Diagram
Nutrients | Free Full-Text | Glycycoumarin Sensitizes Liver Cancer Cells to ABT-737 by Targeting De Novo Lipogenesis and TOPK-Survivin Axis | HTML
Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy - Mohana‐Kumaran - 2014 - Pigment Cell & Melanoma Research - Wiley Online Library
In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas | PNAS
Bim Upregulation by Histone Deacetylase Inhibitors Mediates Interactions with the Bcl-2 Antagonist ABT-737: Evidence for Distinct Roles for Bcl-2, Bcl-xL, and Mcl-1 | Molecular and Cellular Biology
Why do BCL-2 inhibitors work and where should we use them in the clinic? | Cell Death & Differentiation
PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors
The Stress Protein BAG3 Stabilizes Mcl-1 Protein and Promotes Survival of Cancer Cells and Resistance to Antagonist ABT-737* - Journal of Biological Chemistry
Attacking cancer's Achilles heel: antagonism of anti‐apoptotic BCL‐2 family members - Opferman - 2016 - The FEBS Journal - Wiley Online Library
Repurposing apoptosis-inducing cancer drugs to treat schistosomiasis | Future Medicinal Chemistry
The regulation of MCL-1 by Noxa expression and the mechanisms of... | Download Scientific Diagram
ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin–DNA adducts - ScienceDirect
Synergistic co-delivery of diacid metabolite of norcantharidin and ABT-737 based on folate-modified lipid bilayer-coated mesoporous silica nanoparticle against hepatic carcinoma | SpringerLink
